Abstract:ABSTRACT Background Race is a social and not a biological construct. Major societies have recommended removing a race correction factor when estimating glomerular filtration rate (eGFR). eGFR is a strong predictor for acute kidney injury (AKI) after percutaneous coronary intervention (PCI). We assessed the effect of removal of the race correction factor in eGFR calculation on the predictive ability of contemporary models for AKI after PCI. Methods We used data from the American College of Cardiology’s National Cardiovascular Data Registry (NCDR) CathPCI registry to assess the effect of removing a race correction in eGFR calculation on two previously published AKI models developed using NCDR data – a logistic regression-based model and a gradient boosting machine learning (ML) model. We first assessed the calibration and discrimination of these models with and without race correction and subsequently included race as an independent predictor in a model without race-corrected eGFR. We assessed model performance overall, and stratified by Black and non-Black subgroups. The models were trained on the same cohort used to develop the NCDR models and validated with a contemporaneous validation data set. Results We included 947,091 PCI procedures in 915,223 patients (mean age 64.8 years; 7.9% were Black and 32.8% women) with an AKI rate of 7.4%. In the NCDR model, inclusion of race correction in eGFR significantly underestimated AKI risk among Black patients (predicted 7.6% vs observed 10.2%) while slightly overestimating risk among non-Black patients (predicted 7.4% vs observed 7.1%). Removing the race correction partially corrected the underestimation among Black patients (predicted 8.2%). Including race as an independent predictor and introducing interaction terms further reduced the underestimation (predicted 10.1%). The receiver-operating-characteristic curve (AUC) was similar among these models, but was consistently lower in Black patients. Compared with the logistic model, the ML model had better calibration in Black patients (with race correction predicted 8.6% and without 8.7%) but still underestimated AKI risk. With race included as a predictor, the ML model achieved similarly good calibration in Black patients (predicted 10.1%). The AUCs of ML models were better than the logistic models but did not differ based on the inclusion of the race correction. Conclusion Removing the race correction in eGFR calculation has a positive effect of reducing the underestimation of the risk of AKI following PCI for Black patients. However, despite the reduction in underestimation, Black patients remain at elevated risk for AKI compared to non-Black patients. There is a need to better capture the determinants of this higher AKI risk through richer data and advanced modeling techniques.

Estimated glomerular filtration rate among intensive care unit survivors: From the removal of race coefficient to cystatin C-based equations

Impact of Removing Race Adjustment When Estimating GFR on Chronic Kidney Disease Staging

New race-free creatinine- and cystatin C-based equations for the estimation of glomerular filtration rate and association with cardiovascular mortality in the AtheroGene study

Predictive performance of glomerular filtration rate estimation equations based on cystatin C versus serum creatinine values in critically ill patients

Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis

Effect of removing race correction factor in glomerular filtration rate estimation on predicting acute kidney injury after percutaneous coronary intervention

Influence of different reference GFR distribution on racial coefficient in GFR estimating equation

Abstract 16875: Cystatin C- versus Creatinine- Based Assessment of Renal Function in Patients Admitted With Heart Failure: Insights From DOSE, ROSE and CARRESS-HF

Prospective Comparison of Equations Based on Creatinine and Cystatin C for the Glomerular Filtration Rate Estimation in Chinese Renal Transplant Recipients.

Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

Algorithmic Changes Are Not Enough: Evaluating the Removal of Race Adjustment from the eGFR Equation

Elevated serum cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery.

Impact of switching from the 2009 to the 2021 CKD-EPI Equation for eGFR

Toward Equitable Kidney Function Estimation in Critical Care Practice. Guidance From the Society of Critical Care Medicine’s Diversity, Equity, and Inclusion in Renal Clinical Practice Task Force

Comparison of Race-Based and Non-Race-Based Glomerular Filtration Rate Equations for the Assessment of Renal Functional Risk Before Nephrectomy

The Implication of Dropping Race from the MDRD Equation to Estimate GFR in an African American-Only Cohort

Serum Creatinine-to-Cystatin-C Ratio as a Potential Muscle Mass Surrogate and Racial Differences in Mortality

Serum Cystatin C is Associated with Renal Function Recovery in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

Abstract 13537: The Difference Between Cystatin C- and Creatinine-Based Kidney Function Assessment is Associated With Clinical Outcomes, Quality of Life and Frailty in Patients With Heart Failure and Reduced Ejection Fraction: Insights From PARADIGM-HF

Elevated Serum Cystatin C at Continuous Renal Replacement Therapy Initiation Predicts Lack of Renal Recovery

National Estimates of CKD Prevalence and Potential Impact of Estimating Glomerular Filtration Rate Without Race